ConductScience.org, home

Paper23950

Therapeutic and collateral effects of 25-hydroxycholecalciferol in vitamin D deficiency.

Moya M and 2 others. Eur J Pediatr, 1977. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic and collateral effects of 25-hydroxycholecalciferol in vitamin D deficiency. Papers, record 23950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23950

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic and collateral effects of 25-hydroxycholecalciferol in vitamin D deficiency.
PubMed
Journal
Eur J Pediatr
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.13
iCite
Revised in PubMed
2026-10-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moya MM
2Beltran JJ
3Colomer JJ

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HydroxycholecalciferolsMajor topic
RicketsMajor topic
Alkaline Phosphatase
Calcium
Cholecalciferol
Humans
Hydrogen-Ion Concentration
Infant
Phosphorus

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14317911Effects of 25-hydroxycholecalciferol in patients with familial hypophosphatemia and vitamin-D-resistant rickets.N Engl J Med1970https://conductscience.org/library/papers/4317911PubMed
25173755Rickets and osteomalacia of various origins.Birth Defects Orig Artic Ser1971https://conductscience.org/library/papers/5173755PubMed
34343252[Continuous rickets prevention--already in the newborn infant?].Monatsschr Kinderheilkd (1902)1972https://conductscience.org/library/papers/4343252PubMed
4165857Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia.Br Med J1975https://conductscience.org/library/papers/165857PubMed
54267263Regulation of vitamin D metabolism and function.Physiol Rev1973https://conductscience.org/library/papers/4267263PubMed
648776Masked primary (or tertiary) hyperparathyroidism.Lancet1975https://conductscience.org/library/papers/48776PubMed
7433544325-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets.J Clin Invest1972https://conductscience.org/library/papers/4335443PubMed
85583448Hyperparathyroidism as the cause of hyperaminoaciduria and phosphaturia in human vitamin D deficiency.Pediatr Res1967https://conductscience.org/library/papers/5583448PubMed
9430069925-hydroxycholecalciferol. A biologically active metabolite of vitamin D3.Biochemistry1968https://conductscience.org/library/papers/4300699PubMed
104319937Treatment of renal osteodystrophy with 25-hydroxycholecalciferol.Arch Intern Med1970https://conductscience.org/library/papers/4319937PubMed
114578017The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone.N Engl J Med1973https://conductscience.org/library/papers/4578017PubMed
124818766Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxyvitamin D3 in thyroparathyroidectomized rats.Endocrinology1974https://conductscience.org/library/papers/4818766PubMed
131120218I alpha-hydroxycholecalciferol: a treatment of renal bone disease.Br Med J1975https://conductscience.org/library/papers/1120218PubMed
14167901Vitamin D-resistant rickets and 25-hydroxycholecalciferol.Br Med J1975https://conductscience.org/library/papers/167901PubMed
154323313Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism.Nature1971https://conductscience.org/library/papers/4323313PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
35420658Safety of High-Dose Vitamin D Supplementation Among Children Aged 0 to 6 Years: A Systematic Review and Meta-analysis.JAMA Netw Open2022https://conductscience.org/library/papers/35420658PubMed
27826955Vitamin D supplementation for preventing infections in children under five years of age.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/27826955PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23950

GET https://conductscience.org/api/papers/v1/23950/authors